Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Selvin

Showing results (181-190 of 683) with videos related to

Pageof 69
Sort By:
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|May 6, 2022
Changes in Serum Intact Fibroblast Growth Factor 23 Concentrations From Midlife to Late Life and Their Predictors in the Community: The ARIC StudyJunichi Ishigami, Yasuyuki Honda, Amy B Karger, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 25, 2018
Coffee Consumption and Incident Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) StudyEmily A Hu, Elizabeth Selvin, Morgan E Grams, et al.
Plos One|October 11, 2014
Dietary protein intake and coronary heart disease in a large community based cohort: results from the Atherosclerosis Risk in Communities (ARIC) study [corrected]Bernhard Haring, Noelle Gronroos, Jennifer A Nettleton, et al.
Journal of the American Heart Association|November 4, 2024
PREVENT Risk Score and Use of Cardioprotective Agents in Type 2 Diabetes: An Analysis of NHANES 2013 to 2020Lucas A Mavromatis, Dan Wang, Elizabeth Selvin, et al.
Journal of Endocrinology and Metabolism|May 16, 2020
Association Between Thyroid Dysfunction and Incident Dementia in the Atherosclerosis Risk in Communities Neurocognitive StudyKristen M George, Pamela L Lutsey, Elizabeth Selvin, et al.
Diabetologia|August 4, 2021
Diabetes and the risk of hospitalisation for infection: the Atherosclerosis Risk in Communities (ARIC) studyMichael Fang, Junichi Ishigami, Justin B Echouffo-Tcheugui, et al.
Obesity Science & Practice|October 14, 2022
Weight changes following antidiabetic mediation use: Real-world evidence from health system dataBeini Lyu, Morgan E Grams, Lesley A Inker, et al.
Hypertension (Dallas, Tex. : 1979)|July 28, 2020
Isolated Diastolic Hypertension in the UK Biobank: Comparison of ACC/AHA and ESC/NICE Guideline DefinitionsBrian P McGrath, Prosenjit Kundu, Natalie Daya, et al.
Archives of Internal Medicine|September 15, 2005
Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities studyElizabeth Selvin, Josef Coresh, Sherita H Golden, et al.
Arthritis Care & Research|October 6, 2011
Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effectsAndrew L Mammen, Katherine Pak, Emma K Williams, et al.
Pageof 69

Showing results (181-190 of 683) with videos related to

Sort By:
Pageof 69
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|May 6, 2022
Changes in Serum Intact Fibroblast Growth Factor 23 Concentrations From Midlife to Late Life and Their Predictors in the Community: The ARIC StudyJunichi Ishigami, Yasuyuki Honda, Amy B Karger, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 25, 2018
Coffee Consumption and Incident Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) StudyEmily A Hu, Elizabeth Selvin, Morgan E Grams, et al.
Plos One|October 11, 2014
Dietary protein intake and coronary heart disease in a large community based cohort: results from the Atherosclerosis Risk in Communities (ARIC) study [corrected]Bernhard Haring, Noelle Gronroos, Jennifer A Nettleton, et al.
Journal of the American Heart Association|November 4, 2024
PREVENT Risk Score and Use of Cardioprotective Agents in Type 2 Diabetes: An Analysis of NHANES 2013 to 2020Lucas A Mavromatis, Dan Wang, Elizabeth Selvin, et al.
Journal of Endocrinology and Metabolism|May 16, 2020
Association Between Thyroid Dysfunction and Incident Dementia in the Atherosclerosis Risk in Communities Neurocognitive StudyKristen M George, Pamela L Lutsey, Elizabeth Selvin, et al.
Diabetologia|August 4, 2021
Diabetes and the risk of hospitalisation for infection: the Atherosclerosis Risk in Communities (ARIC) studyMichael Fang, Junichi Ishigami, Justin B Echouffo-Tcheugui, et al.
Obesity Science & Practice|October 14, 2022
Weight changes following antidiabetic mediation use: Real-world evidence from health system dataBeini Lyu, Morgan E Grams, Lesley A Inker, et al.
Hypertension (Dallas, Tex. : 1979)|July 28, 2020
Isolated Diastolic Hypertension in the UK Biobank: Comparison of ACC/AHA and ESC/NICE Guideline DefinitionsBrian P McGrath, Prosenjit Kundu, Natalie Daya, et al.
Archives of Internal Medicine|September 15, 2005
Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities studyElizabeth Selvin, Josef Coresh, Sherita H Golden, et al.
Arthritis Care & Research|October 6, 2011
Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effectsAndrew L Mammen, Katherine Pak, Emma K Williams, et al.
Pageof 69